The content is available as a PDF (279.4 KB).
ABO blood groups and COVID-19
Joris R Delanghe
Marc L De Buyzere
Marijn M Speeckaert
Corresponding author: Prof. Dr. Joris R. Delanghe, Department of Diagnostic Sciences, Ghent University Hospital, Corneel Heymanslaan 10, B 9000 Gent, Belgium, e-mail: joris.delanghe@ugent.be, phone: ++ 32 9 332 2956, fax: ++ 32 9 332 4985
Received 2020 Aug 14.
Keywords: COVID-19, ABO polymorphism, prevalence, mortality
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.